Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda.
about
Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidityAntibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidityAzithromycin for treating uncomplicated malariaAzithromycin for treating uncomplicated malariaRandomized controlled trials of interventions to prevent sexually transmitted infections: learning from the past to plan for the future.Chlamydia trachomatis Infection in Pregnancy: The Global Challenge of Preventing Adverse Pregnancy and Infant Outcomes in Sub-Saharan Africa and AsiaA randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant womenGlobal report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions.The History of the HIV/AIDS Epidemic in Africa.Prophylactic antibiotic administration in pregnancy to prevent infectious morbidity and mortality.Pregnancy outcome following gestational exposure to azithromycinThe diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trialMethodologies for evaluating HIV prevention intervention (populations and epidemiologic settings)Immunomodulatory factors in cervicovaginal secretions from pregnant and non-pregnant women: a cross-sectional study.Assessment of azithromycin in combination with other antimalarial drugs against Plasmodium falciparum in vitroAnti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycinEffect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial.Neurodevelopmental benefits of antiretroviral therapy in Ugandan children aged 0-6 years with HIV.Chemistry and biology of macrolide antiparasitic agents.Perinatal HIV transmission: developing country considerations.In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipineWhat's new in azithromyin?Prevalence and risk factors of chlamydia and gonorrhea among rural Nepali women.Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries.The role of co-infections in mother-to-child transmission of HIV.Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation.Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.Rush to judgment: the STI-treatment trials and HIV in sub-Saharan Africa.In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome.Chlamydia and Gonorrhea in HIV-Infected Pregnant Women and Infant HIV TransmissionEpidemiology and aetiology of maternal bacterial and viral infections in low- and middle-income countriesLack of effectiveness of syndromic management in targeting vaginal infections in pregnancy in Entebbe, UgandaAzithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy.Adverse birth outcomes in United Republic of Tanzania--impact and prevention of maternal risk factors.Prevalence of sexually transmitted infections among pregnant women with known HIV status in northern Tanzania.Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies.Epidemiology and control of trachoma: systematic review.Bacterial vaginosis in female facility workers in north-western Tanzania: prevalence and risk factors.Azithromycin prevents pregnancy loss: reducing the level of tumor necrosis factor-alpha and raising the level of interleukin-10 in rats.On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections
P2860
Q24186506-BEC56C01-356D-40D7-AA97-BD176D5CAF07Q24187066-723F925A-8045-4EE5-94F1-698607A4AD00Q24234168-6CCB11A9-AA1C-4F46-9B4A-720B8096E117Q24244733-57AD3A5E-4E29-4186-94B8-DD42AD78DCD2Q24600011-37B1ED49-80D0-4D45-9542-AC6C0985848EQ26752829-F0AD4785-71A3-480F-BDC7-A25825000234Q28469347-92CF494E-1DEB-417F-96F8-7B8D1432DC4AQ30227236-8DE00914-A190-4200-B9B1-EFA88B42A532Q30250286-BDBCBA99-B136-45C6-BEEE-776280841E5CQ30879958-63FFD4D7-689E-4773-BA51-12652A4F6F4FQ33245155-C21F8D83-09E8-4828-B04C-3606FDDECB12Q33378486-25A29A89-0511-4A1F-8DA6-93D6544A9B0AQ33904091-DAA1DFE8-9DCC-465F-A6C4-56967F577B31Q34036250-597C1BE6-61BD-4E84-8F74-B6F704D263D3Q34111879-BC546DA8-058C-4B3E-8163-4D12E19162AAQ34322250-E34FCEA4-C59E-472D-93D2-174F409DFF41Q34341776-376A9CAF-5E4A-4193-9E54-5BCC09D91C0BQ34342177-96512F37-49AE-4814-91A3-A706FE20DEB3Q34904340-A5A3BA91-58C5-4242-A0A6-6C69292921E6Q35046412-7DF36570-005B-49ED-8FD5-BAB97861706CQ35065754-B45988A3-469F-495B-B602-F5CE79F4E5D9Q35230503-7724DF00-09A5-4033-80CA-AAF671D54714Q35531805-61E51E1E-FEBC-462E-BF8A-73B3961151D0Q35531854-B1F9DC4B-A4AD-4A6C-962A-DF236F39FB4CQ35542406-AD9F2330-16EB-43C6-9929-F638EE795E12Q35571562-771D382E-78ED-4044-8DA2-7CDB1816EDFBQ35594099-70967A38-A172-48D8-8C56-285B38D6E174Q35625590-777AF697-8350-4FC0-9A15-86E50B606C2CQ35635904-FE56B793-2EF6-4F8D-A8D1-A05BDDD6989EQ36063383-AF0738B5-D920-48E4-9360-0F9E168DF0C0Q36358973-C8F74A19-FDFC-477D-9C4E-E3D29E75C4A2Q36930472-6623EC67-2C4F-4DD9-A503-3B0BCD38CD9BQ37076814-5DA91705-EA4C-452C-92DC-C6DE3BBA9DC3Q37084492-4CB640C9-482B-4018-AA5E-AC8075D86B48Q37126259-3C146318-D1E4-4925-882D-D29DBAFC4320Q37136326-F2F1A5FC-F43B-4435-9610-17B94A0552C8Q37165258-B98AA0C8-C66D-47CC-A66E-1600DCEFBFA5Q37259390-44358E21-A307-49CE-AE07-B18DE09FF838Q37383429-15C2DE4E-A1E8-41D2-BC12-17380303E9F0Q37530197-3EB4963E-AA89-4DA0-BBE6-7924889D6E72
P2860
Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Randomized trial of presumptiv ...... ng pregnancy in Rakai, Uganda.
@en
Randomized trial of presumptiv ...... ng pregnancy in Rakai, Uganda.
@nl
type
label
Randomized trial of presumptiv ...... ng pregnancy in Rakai, Uganda.
@en
Randomized trial of presumptiv ...... ng pregnancy in Rakai, Uganda.
@nl
prefLabel
Randomized trial of presumptiv ...... ng pregnancy in Rakai, Uganda.
@en
Randomized trial of presumptiv ...... ng pregnancy in Rakai, Uganda.
@nl
P2093
P921
P356
P1476
Randomized trial of presumptiv ...... ng pregnancy in Rakai, Uganda.
@en
P2093
Abramowsky C
Moulton LH
O'Brien KL
Serwadda D
Sewankambo NK
P304
P356
10.1067/MOB.2001.118158
P407
P577
2001-11-01T00:00:00Z